Top compounds associated with response to LRRC4C


Feature Type Standardized
Nominal ANOVA
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.14 2e-05
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.15 2e-05
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA PX-12 CTRPv2 pan-cancer AAC 0.12 3e-05
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.13 3e-05
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.16 3e-05
mRNA BX-912 GDSC1000 pan-cancer AAC 0.13 4e-05
mRNA PL-DI CTRPv2 pan-cancer AAC 0.14 6e-05
Download CSV